Abstract:Dosage and duration of beneficial effect of botulinum toxin in treatment of adductor laryngeal dystonia do not appear to vary with age or gender.
“…In our population, dosing varies widely between patients. As in other dystonias, we find that BoNT dose in AdSD is not related to either sex or age 20. Furthermore, we observe that each patient's symptoms and dose tend to vary over time.…”
It is important to consider longitudinal functional outcomes in BoNT treatment of AdSD. An individuated dosing regimen helps minimize side effects and maximize functional and quality-of-life outcomes.
“…In our population, dosing varies widely between patients. As in other dystonias, we find that BoNT dose in AdSD is not related to either sex or age 20. Furthermore, we observe that each patient's symptoms and dose tend to vary over time.…”
It is important to consider longitudinal functional outcomes in BoNT treatment of AdSD. An individuated dosing regimen helps minimize side effects and maximize functional and quality-of-life outcomes.
“…This retrospective chart review reveals a statistically and clinically significant correlation between female gender and higher average BoNTA dose for symptom control in adductor SD. Vasconcelos et al conducted a retrospective review with a slightly smaller cohort examining the influence of age and gender on dosing effectiveness of botulinum toxin (BTX) for laryngeal dystonia . Their hypothesis was that the average BTX dose for males would be greater than for females due to the increased male muscle volume and therefore greater number of neuromuscular junctions for BoNTA to act upon.…”
Section: Discussionmentioning
confidence: 99%
“…conducted a retrospective review with a slightly smaller cohort examining the influence of age and gender on dosing effectiveness of botulinum toxin (BTX) for laryngeal dystonia. 7 Their hypothesis was that the average BTX dose for males would be greater than for females due to the increased male muscle volume and therefore greater number of neuromuscular junctions for BoNTA to act upon. Their results, however, were to the contrary and revealed a higher dose for the female (2.15 U) versus male group (1.85 U).…”
“…52 The first BoNT toxin injection for the treatment of laryngeal dystonia was given by Biltzer in 1984 and since then BoNT injection has become the main treatment modality. 53 For adductor laryngeal dystonia, injection of one or both of the thyroarytenoid muscles is performed. Using EMG, a needle is passed through the cricothyroid membrane in the midline and is angled superior lateral in the direction of the thyroarytenoid muscles.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.